Healthcare -
Biotechnology - NASDAQ - US
$ 21.4
3.68 %
$ 1.9 B
Market Cap
-5.26
P/E
TVTX - LONG-TERM DEBT
Long-term Debt TVTX - Travere Therapeutics, Inc.
328 M
LAST VALUE
-12.79%
2 YEAR CAGR
9.84%
5 YEAR CAGR
22.43%
10 YEAR CAGR